Molecule2Market offers our clients the simplicity of support through one organisation. We provide services across a range of disciplines involved in pharmaceutical and device research, development and commercialisation in a highly flexible manner to meet customer needs.

Conducting research in Australia

Did you know you the R&D Tax Incentive program is the Australian Government’s principle measure to enhance and increase the amount of research and development undertaken by Australian businesses?

The R&D Tax Incentive provides eligible entities with a tax offset for expenditure on eligible R&D activities and for the decline in value of depreciating assets used for eligible R&D activities.

The R&D Tax Incentive replaced the previous R&D Tax Concession for income years commencing on or after 1 July 2011.

The objectives of the R&D Tax Incentive program are to provide a tax offset to make eligible companies more competitive and improve productivity across the Australian economy by:

  • encouraging industry to conduct R&D that may not otherwise have been conducted
  • providing business with more predictable, less complex support
  • improving the incentive for smaller firms to engage in R&D

Molecule2Market can provide you with a local R&D tax expert who can walk you through the requirements to qualify for these incentives, and help you every step of the way.

Lets have a chat about your project.

Fill out the form and we will be in touch.